Greenleaf Peter
Pelthos Therapeutics Inc. · Director
Greenleaf Peter is listed in filings as Director at Pelthos Therapeutics Inc.. This profile follows SEC Form 4 activity through Apr 6, 2026, including sale activity. Recent filings connect the profile to Pelthos Therapeutics Inc. (PTHS) and Aurinia Pharmaceuticals Inc. (AUPH). The current snapshot covers public activity from Mar 4, 2025 to Apr 6, 2026. Reported amounts are shown as $8.6K to $1.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1M164.9k shares | SellMar 4, 2025 | $7.92 | $15.94 | |
| $2M195.6k shares | SellMar 3, 2025 | $8.00 | $15.94 |